文献速递前列腺癌

包含MRI特征的列线图预测侧别特异性前列腺外侵犯的外部验证

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2023-11-06

本研究回顾性收集2017至2021年四家欧洲三级转诊中心接受机器人辅助根治性前列腺切除术的前列腺癌患者数据,外部验证四个包含MRI信息的侧别特异性前列腺外侵犯预测列线图,评估区分度、校准度和净获益。结果显示Nyarangi-Dix、Martini和Soeterik列线图预测准确,可用于支持医疗决策。

要点

  • 在773例患者1546个前列腺叶中,338个(22%)叶存在前列腺外侵犯。
  • 四个列线图预测前列腺外侵犯的AUC范围为72.2%至75.5%,最高为Nyarangi-Dix列线图。
  • Nyarangi-Dix、Martini和Soeterik列线图校准良好,适用于支持医疗决策。

核心结论

  • Nyarangi-Dix、Martini和Soeterik列线图能准确预测前列腺外侵犯,因此适合用于支持医疗决策。

研究设计与样本

  • 回顾性收集2017至2021年四家欧洲三级转诊中心接受机器人辅助根治性前列腺切除术的前列腺癌患者数据,外部验证四个先前开发的侧别特异性前列腺外侵犯预测列线图。
  • 共纳入773例患者,总计1546个前列腺叶。

主要发现

  • 338个(22%)前列腺叶存在前列腺外侵犯。
  • 预测前列腺外侵犯的模型AUC范围为72.2%(95%CI 69.1-72.3%)(Wibmer)至75.5%(95%CI 72.5-78.5%)(Nyarangi-Dix)。
  • AUC最高的列线图在不同队列中有所不同。
  • Soeterik、Nyarangi-Dix和Martini列线图在5%至30%的临床最相关阈值范围内显示中等至良好校准;Wibmer列线图在阈值高于25%时明显高估前列腺外侵犯风险。
  • 在20%至30%风险阈值范围内,Nyarangi-Dix列线图相比其他三个列线图显示更高的净获益。

关键数值与推荐

  • 预测前列腺外侵犯的模型AUC范围:Wibmer 72.2%(95%CI 69.1-72.3%)至Nyarangi-Dix 75.5%(95%CI 72.5-78.5%)。
  • Soeterik、Nyarangi-Dix和Martini列线图在5%至30%阈值范围内校准中等至良好。
  • Wibmer列线图在阈值高于25%时明显高估前列腺外侵犯风险。
  • Nyarangi-Dix列线图在20%至30%风险阈值范围内净获益高于其他三个列线图。
  • 欧洲泌尿生殖放射学会评分和肿瘤包膜接触长度在所有MRI特征中AUC最高、AIC最低。

临床怎么用

  • Nyarangi-Dix、Martini和Soeterik列线图预测准确,适合用于支持医疗决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prediction of side-specific extraprostatic extension (EPE) is crucial in selecting patients for nerve-sparing radical prostatectomy (RP). Multiple nomograms, which include magnetic resonance imaging (MRI) information, are available predict side-specific EPE. It is crucial that the accuracy of these nomograms is assessed with external validation to ensure they can be used in clinical practice to support medical decision-making. METHODS: Data of prostate cancer (PCa) patients that underwent robot-assisted RP (RARP) from 2017 to 2021 at four European tertiary referral centers were collected retrospectively. Four previously developed nomograms for the prediction of side-specific EPE were identified and externally validated. Discrimination (area under the curve [AUC]), calibration and net benefit of four nomograms were assessed. To assess the strongest predictor among the MRI features included in all nomograms, we evaluated their association with side-specific EPE using multivariate regression analysis and Akaike Information Criterion (AIC). RESULTS: This study involved 773 patients with a total of 1546 prostate lobes. EPE was found in 338 (22%) lobes. The AUCs of the models predicting EPE ranged from 72.2% (95% CI 69.1-72.3%) (Wibmer) to 75.5% (95% CI 72.5-78.5%) (Nyarangi-Dix). The nomogram with the highest AUC varied across the cohorts. The Soeterik, Nyarangi-Dix, and Martini nomograms demonstrated fair to good calibration for clinically most relevant thresholds between 5 and 30%. In contrast, the Wibmer nomogram showed substantial overestimation of EPE risk for thresholds above 25%. The Nyarangi-Dix nomogram demonstrated a higher net benefit for risk thresholds between 20 and 30% when compared to the other three nomograms. Of all MRI features, the European Society of Urogenital Radiology score and tumor capsule contact length showed the highest AUCs and lowest AIC. CONCLUSION: The Nyarangi-Dix, Martini and Soeterik nomograms resulted in accurate EPE prediction and are therefore suitable to support medical decision-making.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Heetman JG, van der Hoeven EJRJ, Rajwa P, et al. External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension. Prostate Cancer Prostatic Dis. 2023. PMID: 37932522. doi:10.1038/s41391-023-00738-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。